Education
About Us
Working with TipRanks
Follow Us
Emergent Biosolutions (EBS)
:EBS
Earnings Data
Report Date
Aug 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.1Last Year’s EPS
-2.32Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: 31.86%
|Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative elements. While the company reported strong improvements in financial metrics, international revenue growth, and strategic agreements, challenges such as a decline in total revenue and specific issues with NARCAN sales were highlighted. The overall sentiment reflects a balanced outlook with significant achievements offset by notable challenges.Company Guidance
During the first quarter of 2025, Emergent BioSolutions reaffirmed its outlook and guidance for the full year, projecting total revenues between $750 million and $850 million and adjusted EBITDA ranging from $150 million to $200 million. The company reported a strong start to the year with first-quarter revenues of $222 million and an adjusted EBITDA of $78 million, marking an increase of $11 million compared to the previous year. Emergent's net income for the quarter was $68 million, a substantial 656% increase from the first quarter of 2024. The company also reported an improved cash position with $149 million on the balance sheet and total liquidity of $249 million. Their net leverage ratio was significantly reduced to 2.8x adjusted EBITDA from 5.7x in the first quarter of 2024. Emergent's MCM product sales were projected between $435 million and $485 million, while commercial products, including NARCAN, were expected to generate revenues in the range of $265 million to $315 million. The company also highlighted strong international sales, with $91 million in MCM sales outside the United States during the quarter.Improved Financial Position
Emergent BioSolutions improved its cash position, ending Q1 2025 with $149 million on the balance sheet and a total liquidity of $250 million, including a fully undrawn revolver. Net leverage reduced to 2.8x adjusted EBITDA from 5.7x in Q1 2024.
International Revenue Growth
International sales accounted for $91 million of total revenue, representing about 40% of overall revenue and 60% of medical countermeasures revenue, indicating significant diversification and growth outside the U.S.
Significant Margin Expansion
Adjusted EBITDA margin improved by 1,300 basis points to 35%, and adjusted gross margin increased by 700 basis points year-over-year.
Large Contract with Ontario Ministry of Health
A 3-year agreement valued at approximately $65 million was signed with the Province of Ontario for supplying NARCAN, demonstrating continued demand and support for Emergent's opioid overdose reversal treatments.
Strong Start to 2025
Net income for Q1 2025 was $68 million, a 656% increase compared to Q1 2024, highlighting significant financial improvement.
EBS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
EBS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2025 | $4.74 | $6.36 | +34.18% |
Mar 03, 2025 | $6.83 | $6.39 | -6.44% |
Nov 06, 2024 | $9.20 | $11.00 | +19.57% |
Aug 06, 2024 | $9.86 | $5.72 | -41.99% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Emergent Biosolutions (EBS) report earnings?
Emergent Biosolutions (EBS) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
What is Emergent Biosolutions (EBS) earnings time?
Emergent Biosolutions (EBS) earnings time is at Aug 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EBS EPS forecast?
EBS EPS forecast for the fiscal quarter 2025 (Q2) is -0.1.